GlassScriptPhysician profile
Faisal A Bahadur
NPI 1144421355
$12,361.38
in general payments reported to CMS, 2019-2025
52 companies · $1,828 in 2025
The $1,828 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,788 · 2020: $1,063 · 2021: $1,280 · 2022: $1,976 · 2023: $1,839 · 2024: $2,586 · 2025: $1,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,656 · Travel and Lodging: $494 · Debt Forgiveness: $93.06 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,656.19 |
| Travel and Lodging | $493.72 |
| Debt Forgiveness | $93.06 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,172.54 | 2019-2025 | |
| Abiomed | $989.84 | 2020-2025 | Impella |
| Janssen Pharmaceuticals, INC | $816.16 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $633.23 | 2021-2025 | Verquvo, Capvaxive, Winrevair |
| Amgen INC. | $594.27 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $570.80 | 2019-2025 | Mitraclip, Aveir, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $555.49 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $537.86 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $516.01 | 2019-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $498.92 | 2019-2024 | Wainua, Farxiga, Andexxa |
| Boston Scientific Corporation | $483.49 | 2019-2025 | Watchman Flx, Rotapro, Varithena Administration Pack |
| Baxter Healthcare | $450.07 | 2022-2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Bardy Diagnostics, INC. | $429.44 | 2019-2022 | |
| Heartflow, INC. | $382.49 | 2024-2025 | |
| Pfizer INC. | $365.01 | 2019-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $341.53 | 2020-2025 | Opsumit, Uptravi |
| Kestra Medical Technology Services, INC. | $331.37 | 2024-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $260.06 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biotronik INC. | $239.97 | 2019-2024 | |
| Chiesi USA, INC. | $224.37 | 2019-2025 | Kengreal, Cleviprex |
| Cardiovascular Systems INC. | $218.45 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $180.32 | 2020-2023 | |
| Atricure, INC. | $158.00 | 2022-2024 | |
| Biosense Webster, INC. | $134.67 | 2025 | Carto 3 |
| Medtronic, INC. | $100.40 | 2021-2025 | Closurefast, Corevalve Evolut R |
| Alnylam Pharmaceuticals INC. | $100.40 | 2022-2024 | Amvuttra |
| Amarin Pharma, INC. | $100.08 | 2019-2021 | |
| Novo Nordisk INC | $91.67 | 2024-2025 | Ozempic, Wegovy |
| Bridgebio Pharma, INC. | $82.09 | 2025 | Attruby |
| Esperion Therapeutics, INC. | $67.32 | 2020-2022 | |
| Lexicon Pharmaceuticals, INC. | $58.23 | 2023-2024 | Inpefa |
| Gilead Sciences, INC. | $55.48 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $54.74 | 2019-2024 | Evkeeza |
| Philips North America LLC | $50.04 | 2021-2023 | |
| Lundbeck LLC | $49.33 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $45.68 | 2021 | |
| Medtronic Vascular, INC. | $45.38 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $41.15 | 2024 | Arcalyst |
| Astellas Pharma US INC | $37.85 | 2020 | |
| Scpharmaceuticals INC. | $29.96 | 2023-2024 | |
| Impulse Dynamics (USA) INC. | $28.07 | 2022 | |
| Cook Medical LLC | $27.09 | 2024 | Zilver Ptx |
| Daiichi Sankyo INC. | $26.33 | 2023 | Injectafer |
| Tactile Systems Technology INC | $26.04 | 2019 | |
| Medicure Pharma INC. | $23.65 | 2019 | |
| Organogenesis INC. | $23.05 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.93 | 2023 | |
| Bard Peripheral Vascular, INC. | $21.54 | 2023 | Rotarexs 6 F X 135 Cm |
| Cardinal Health 200 LLC | $20.00 | 2019 | |
| Itamar Medical INC | $19.20 | 2022 | |
| Nevro Corp. | $15.57 | 2023 | Senza |
| Infobionic, INC | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Bahadur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.